Skip to main content
logo
Proteomics International Laboratories Ltd (ASX:PIQ)
Australia flag Australia · Delayed Price · Currency is AUD
0.1350
-0.0050 (-3.57%)
Sep 18, 2026, 12:24 PM AEST

ASX:PIQ Revenue

In the fiscal year ending June 30, 2026, Proteomics International Laboratories had annual revenue of 3.37M AUD with 1.75% growth. Proteomics International Laboratories had revenue of 2.64M in the half year ending June 30, 2026, a decrease of -0.39%.

Revenue
3.37M
Revenue Growth
+1.75%
P/S Ratio
6.87
Revenue / Employee
n/a
Employees
n/a
Market Cap
23.15M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20263.37M57.85K1.75%
Jun 30, 20253.31M43.87K1.34%
Jun 30, 20243.27M87.53K2.75%
Jun 30, 20233.18M-249.17K-7.26%
Jun 30, 20223.43M694.47K25.38%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
EZZ Life Science Holdings46.28M
Radiopharm Theranostics13.50M
Immuron7.71M
Argenica Therapeutics5.48M
Neurotech International4.73M
Imugene2.09M
Noxopharm1.43M
Nexsen1.09M
Revenue Rankings

Proteomics International Laboratories News

More News